Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models
Michał Kopczyński(The Maria Sklodowska-Curie National Research Institute of Oncology), Michał Mikuła(National Institute of Oncology)
Cited by 22
Related Papers
Molecular defense mechanisms of Barrett’s metaplasia estimated by an integrative genomics
|Journal of Molecular Medicine|2007|53